Nephrology & Kidney Research
Advancing Kidney Impairment Clinical Research
Kidney impairment affects millions of individuals worldwide and can significantly impact overall health and quality of life. CenExel partners with sponsors to advance innovative therapies for chronic kidney disease (CKD), renal impairment, and related metabolic conditions through specialized clinical research and experienced patient care.
Studies Conducted
0
+
Trial Participants
0
+
Active Sites
0
+
Overview
Leading Kidney Impairment Clinical Research
CenExel delivers specialized kidney impairment clinical trials through experienced nephrology investigators, advanced research capabilities, and diverse patient populations. Our sites support sponsors with efficient enrollment, precise protocol execution, and high-quality data collection from early-phase through late-phase renal studies.
Conditions Covered
Kidney Conditions We Research
Our nephrology research sites support a broad range of kidney impairment and renal-related conditions across adult and senior populations.
- Chronic Kidney Disease (CKD)
- Acute Kidney Injury (AKI)
- Diabetic Nephropathy
- End-Stage Renal Disease (ESRD)
- Polycystic Kidney Disease
- Hypertension-Related Kidney Disease
- Glomerulonephritis
- Lupus Nephritis
Our Approach
Why Sponsors Choose CenExel for Kidney Research
CenExel provides scientific expertise, operational excellence, and access to diverse patient populations for kidney impairment clinical trials.
01
Expert Nephrology Teams
Our experienced investigators and site staff support efficient renal study execution and patient monitoring.
02
Biomarker & Lab Expertise
Advanced renal biomarker testing and laboratory coordination improve study accuracy and efficiency.
03
Diverse Patient Access
Access to broad patient populations across multiple U.S. research locations enhances recruitment success.
04
High-Quality Trial Execution
Our proven enrollment strategies help accelerate kidney impairment clinical trial timelines.
Phase Coverage
Supported Kidney Research Trial Phases
CenExel supports early and late-phase nephrology research studies from proof-of-concept through Phase IV post-market trials.
Active across all phases
- Phase I
- Phase II
- Phase III
- Phase IV
Our psychiatry research network supports biomarker strategies, decentralized trial components, and patient-focused study execution for anxiety-related indications.
Kidney Research Task Force
CenExel supports renal and nephrology-focused studies across chronic kidney disease, diabetic nephropathy, and related metabolic disorders in diverse patient populations.
Active Sites
18 Sites
CenExel Phoenix
CenExel Anaheim
CenExel Atlanta
CenExel Marlton
CenExel Gaithersburg
